Revenue & MarginsSustained revenue growth and stable gross/net margins indicate durable demand and operational efficiency. Consistent EBIT/EBITDA margins support reinvestment capacity, fund R&D and capacity expansion, and underpin long-term profitability across business cycles.
Balance Sheet StrengthLow leverage and a high equity ratio provide financial flexibility for multi-year capex and strategic investments, reduce refinancing risk, and increase resilience to sector swings, supporting durable funding for growth initiatives and customer contracts.
Customer Partnerships & R&DLong-term pharma partnerships deliver recurring, multi-year revenue visibility while R&D investment sustains product differentiation in peptides. Together these create structural competitive advantage and support continued higher-margin proprietary and contract work.